Arbutus Biopharma Corp Class of Warrant or Right, Outstanding
Arbutus Biopharma Corp (ABUS) had Class of Warrant or Right, Outstanding of 0 shares as of 2019-12-31, per its 10-K filed 2020-03-05.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2020-03-05
- 2019-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2018-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2016-12-31: Class of Warrant or Right, Outstanding 201.00K shares.
- 2016-09-30: Class of Warrant or Right, Outstanding 201.00K shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2019-12-31 | 0.00 shares 10-K · filed 2020-03-05 | |
| 2018-12-31 | 0.00 shares 10-K · filed 2019-03-07 | |
| 2016-12-31 | 201.00K shares 10-K · filed 2017-03-22 | |
| 2016-09-30 | 201.00K shares 10-Q · filed 2016-11-03 | |
| 2016-06-30 | 201.00K shares 10-Q · filed 2016-08-04 | |
| 2016-03-31 | 379.50K shares 10-Q · filed 2016-05-04 | |
| 2015-12-31 | 379.50K shares 10-K · filed 2017-03-22 | |
| 2015-09-30 | 379.50K shares 10-Q · filed 2015-11-05 | |
| 2015-06-30 | 379.50K shares 10-Q · filed 2015-08-07 | |
| 2015-03-31 | 386.75K shares 10-Q · filed 2015-05-06 | |
| 2014-12-31 | 398.25K shares 10-K · filed 2016-03-09 | |
| 2014-09-30 | 468.35M shares 10-Q · filed 2014-11-07 | |
| 2013-12-31 | 1.01M shares 10-K · filed 2015-03-13 | 1.01B shares 10-Q · filed 2014-11-07 |
| 2012-02-29 | 924.30K shares 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |